Lack of Effect of SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2, in a Transgenic Murine Model of Retinoblastoma

SU1498, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2), has activity against retinal neovascular diseases. To determine if this drug might have clinical utility against retinoblastoma, we evaluated the effects of SU1498, as well as the expression of VEGFR-2, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cebulla, C.M, Jockovich, M.E, Boutrid, H, Piña, Y, Ruggeri, M, Jiao, S, Bhattacharya, S.K, Feuer, W.J, Murray, T.G
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694596/
https://www.ncbi.nlm.nih.gov/pubmed/19517030
http://dx.doi.org/10.2174/1874364100802010062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694596/
https://www.ncbi.nlm.nih.gov/pubmed/19517030
http://dx.doi.org/10.2174/1874364100802010062

Ejemplares similares